跳至主要内容
临床试验/IRCT20221130056672N7
IRCT20221130056672N7招募中1 期

Investigating the Safety and Efficacy of Human Umbilical Cord Blood Serum (HUCBS) Microneedle compared to only Microneedling for Acne Scar treatment (clinical trial phase ?)

Research Vice President of Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Patients with rolling acne scars with different severity (according to the Goodman grading system)
  • Complete consent of the patient to participate in the plan
  • Age 18 years and above and less than 50 years.

排除标准

  • Being positive in terms of the following: active inflammatory acne, active herpes labialis, local infections in the treatment area, prone to keloids, malignancy, pregnancy, breastfeeding, taking drugs that can affect bleeding or clotting mechanisms, immunosuppression, use of local and systemic steroids, systemic diseases), high blood pressure, diabetes, heart, kidney and liver diseases)
  • Using peels 4 weeks before treatment
  • It should not be done in areas where botulinum injection has been done due to the possibility of microneedle toxin release
  • Positive history of bleeding or platelet disorder, positive history of major surgery in the last 6 months, presence of any acute facial infection such as herpes, folliculitis. HIV patients, HBsAg or any chronic disease

研究者

发起方
Research Vice President of Tehran University of Medical Sciences

相似试验